Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 13 studies | 53% ± 29% | |
oligodendrocyte precursor cell | 13 studies | 41% ± 18% | |
microglial cell | 12 studies | 36% ± 18% | |
GABAergic neuron | 11 studies | 56% ± 30% | |
fibroblast | 7 studies | 33% ± 16% | |
amacrine cell | 7 studies | 37% ± 19% | |
interneuron | 6 studies | 63% ± 28% | |
neuron | 5 studies | 38% ± 13% | |
astrocyte | 5 studies | 47% ± 22% | |
endothelial cell | 4 studies | 33% ± 15% | |
GABAergic interneuron | 3 studies | 65% ± 13% | |
GABAergic amacrine cell | 3 studies | 73% ± 11% | |
glycinergic amacrine cell | 3 studies | 53% ± 19% | |
hepatocyte | 3 studies | 43% ± 17% | |
retinal pigment epithelial cell | 3 studies | 55% ± 15% | |
ciliated cell | 3 studies | 29% ± 7% | |
transit amplifying cell | 3 studies | 41% ± 32% | |
granule cell | 3 studies | 39% ± 22% | |
oligodendrocyte | 3 studies | 44% ± 29% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 93% | 1221.38 | 228 / 245 | 96% | 12.34 | 481 / 502 |
adrenal gland | 100% | 3498.55 | 258 / 258 | 87% | 5.44 | 200 / 230 |
pancreas | 97% | 546.05 | 318 / 328 | 87% | 3.66 | 154 / 178 |
intestine | 91% | 503.06 | 875 / 966 | 83% | 2.90 | 438 / 527 |
kidney | 100% | 849.02 | 89 / 89 | 70% | 2.51 | 635 / 901 |
brain | 94% | 904.75 | 2489 / 2642 | 74% | 1.87 | 519 / 705 |
thymus | 100% | 1247.04 | 651 / 653 | 50% | 0.99 | 300 / 605 |
lung | 100% | 2644.86 | 576 / 578 | 44% | 1.45 | 509 / 1155 |
breast | 58% | 718.08 | 268 / 459 | 79% | 5.63 | 887 / 1118 |
stomach | 50% | 144.99 | 180 / 359 | 80% | 2.90 | 228 / 286 |
liver | 95% | 467.11 | 215 / 226 | 34% | 0.95 | 137 / 406 |
bladder | 52% | 437.43 | 11 / 21 | 52% | 1.90 | 263 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.45 | 1 / 1 |
spleen | 99% | 1064.04 | 239 / 241 | 0% | 0 | 0 / 0 |
skin | 45% | 130.74 | 806 / 1809 | 44% | 1.12 | 206 / 472 |
uterus | 53% | 955.85 | 90 / 170 | 21% | 0.75 | 97 / 459 |
ovary | 50% | 201.99 | 90 / 180 | 19% | 0.33 | 83 / 430 |
esophagus | 15% | 36.53 | 214 / 1445 | 43% | 1.63 | 78 / 183 |
lymph node | 0% | 0 | 0 / 0 | 41% | 1.44 | 12 / 29 |
heart | 32% | 141.25 | 274 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.33 | 8 / 45 |
peripheral blood | 14% | 70.68 | 134 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 0.23 | 9 / 80 |
adipose | 3% | 8.61 | 32 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 3.54 | 18 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.45 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0086012 | Biological process | membrane depolarization during cardiac muscle cell action potential |
GO_0060372 | Biological process | regulation of atrial cardiac muscle cell membrane repolarization |
GO_0045762 | Biological process | positive regulation of adenylate cyclase activity |
GO_0007605 | Biological process | sensory perception of sound |
GO_0007188 | Biological process | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
GO_1901379 | Biological process | regulation of potassium ion transmembrane transport |
GO_0086002 | Biological process | cardiac muscle cell action potential involved in contraction |
GO_0098703 | Biological process | calcium ion import across plasma membrane |
GO_1901016 | Biological process | regulation of potassium ion transmembrane transporter activity |
GO_0086046 | Biological process | membrane depolarization during SA node cell action potential |
GO_0070509 | Biological process | calcium ion import |
GO_0086091 | Biological process | regulation of heart rate by cardiac conduction |
GO_0051928 | Biological process | positive regulation of calcium ion transport |
GO_0006816 | Biological process | calcium ion transport |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_1990454 | Cellular component | L-type voltage-gated calcium channel complex |
GO_0030018 | Cellular component | Z disc |
GO_0005891 | Cellular component | voltage-gated calcium channel complex |
GO_0086059 | Molecular function | voltage-gated calcium channel activity involved SA node cell action potential |
GO_0086007 | Molecular function | voltage-gated calcium channel activity involved in cardiac muscle cell action potential |
GO_0051393 | Molecular function | alpha-actinin binding |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0030506 | Molecular function | ankyrin binding |
GO_0008331 | Molecular function | high voltage-gated calcium channel activity |
GO_0005515 | Molecular function | protein binding |
GO_0005262 | Molecular function | calcium channel activity |
Gene name | CACNA1D |
Protein name | Calcium voltage-gated channel subunit alpha1 D Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Voltage-gated calcium channel subunit alpha Cav1.3) Voltage-dependent L-type calcium channel subunit alpha |
Synonyms | CACNL1A2 CCHL1A2 CACH3 CACN4 |
Description | FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1D gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkylamines, and by benzothiazepines. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . |
Accessions | ENST00000636938.1 A0A1B0GU49 H7C4S8 A0A1B0GW98 A0A1B0GTN0 A0A1B0GVI2 A0A1W2PQ56 ENST00000638120.1 ENST00000645528.2 ENST00000422281.7 [Q01668-3] A0A1B0GUB6 ENST00000481478.2 A0A1B0GTP8 ENST00000640483.1 ENST00000636627.2 A0A1B0GUH2 ENST00000638129.1 ENST00000636723.1 A0A5F9Z6M3 A0A7G9IPG1 ENST00000481085.5 H0Y879 ENST00000636448.1 ENST00000288139.11 [Q01668-2] ENST00000637714.1 Q01668 ENST00000636570.1 A0A1B0GUN6 A0A1B0GWF7 ENST00000350061.11 [Q01668-1] ENST00000637301.1 A0A1B0GWE1 ENST00000637424.1 |